Free access supported by contributions and sponsoring — share your knowledge or support us financially
Search / Compare / Validate Lab equipment & Methods
Sourced in United States, China, Japan, Germany, France, United Kingdom, Italy, Spain, Austria, Israel, Australia, Belgium, Canada, Egypt, Poland, Holy See (Vatican City State), India, Switzerland
About the product

HepG2 is a human liver cell line derived from the liver tissue of a 15-year-old Caucasian male with a well-differentiated hepatocellular carcinoma. It is a widely used in vitro model for the study of liver cell biology and function.

Automatically generated - may contain errors

Market Availability & Pricing

Hep G2 [HEPG2] is an officially listed cell line available through authorized distributors. The current price for this product is $555.00 per vial from the American Type Culture Collection (ATCC).

Need Operating Instructions, SDS, or distributor details? Just ask our AI Agent.

Is this product still available?

Get pricing insights and sourcing options

Product FAQ

3 913 protocols using «hepg2»

1

Algal Biomass-Based Nanocomposite for Cancer Treatment

2025
The dried algal biomass of S. maxima was supplied by the Hydrobiology Lab of the Water Pollution Research Department at the National Research Centre in Giza, Egypt. Tetraethyl orthosilicate (TEOS) and Tween 80 were acquired from Scientific Fischer Co. (USA). The cancer cell lines MCF-7 and HepG2 were purchased from the American Type Culture Collection (ATCC), located in Virginia, (USA). Tissue culture media was obtained from Invitrogen-Life Technologies. MTT was purchased from Acros Organics™ Thermo Fisher Scientific, USA. DOX was obtained from the drugstore in Egypt. Female CD1 Swiss albino mice were provided by the animal facility at the National Research Centr in Giza, Egypt.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
2

Cytotoxicity Screening of Mycotoxins in HepG2 Cells

2025
The human hepatocarcinoma cell line HepG2 was purchased from the American Type Culture Collection (ATCC HB-8065). Dulbecco’s Modified Eagle Medium (DMEM-GlutamaxTM) with high glucose (4.5 g/L), Phosphate-Buffered Saline (PBS), Newborn Calf Serum (NBCS), penicillin, streptomycin, and trypsin-EDTA 0.5% were obtained from Gibco (Thermo Fisher Scientific, Waltham, MA, USA). Dimethyl sulfoxide (DMSO) and methanol were acquired from Fisher Scientific (Madrid, Spain). The standards of AZX (purity ≥ 98%, MW 403.39 g/mol), DON (purity ≥ 98%, 296.32 MW g/mol), OTA (purity ≥ 97%, MW 403.81 g/mol), T2 (purity ≥ 98%, MW 466.52 g/mol), thiazolyl blue tetrazolium bromide (MTT), and the resazurin sodium salt were supplied by Sigma-Aldrich (St Louis, MO, USA). All the reagents and cell culture components were of standard laboratory grade.
The fungicide and the mycotoxins were prepared as stock solutions in DMSO and methanol, respectively. These solutions were stored at −20 °C until use. Working concentrations were then prepared in a DMEM-supplement medium with a maximum solvent concentration of 0.1% in the test solutions. Negative controls containing the appropriate amounts of solvents were included in every experiment.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
3

Ferroptosis Modulation in Cell Lines

2025
The human melanoma cell lines A375, SK-MEL-28, human lung cell line A549, human colorectal cancer cell lines HT29, RKO, human hepatocellular carcinoma cell line Huh-7, HepG2, human fibrosarcoma cell line HT1080 and human embryonic kidney cell line HEK293T were obtained from the American Type Culture Collection (ATCC), and human melanoma cell line SK-MEL-30 was given from Dr. Jun Wan’ laboratory in Shenzhen PKU-HKUST Medical Centre in China. All cell lines were cultured in DMEM medium (Gibco, C11995500BT) supplemented with 10% fetal bovine serum (FBS) (Excell, FSP100) at 37 °C incubator with 5% CO2.
All cells were cultured in a 10 cm plate and subcultured into 96-well- or 6-well plates for cell death, cell viability and lipid-peroxidation measurements. The cells were treated with reagents including the ferroptosis inducers RSL3 (Selleck, S8155) and erastin (Selleck, S7242), ferroptosis inhibitors Ferrostatin-1 (Fer-1) (Selleck, S7243), apoptosis inhibitor Z-VAD-FMK (Z-V) (Selleck, S7023), necrosis inhibitor Necrostatin-1 (Nec-1) (Selleck, S8037), autophagy inhibitor Bafilomycin A1 (Baf-A1) (Selleck, S1413), SLC25A1 inhibitor BTA (Macklin, B801861), ACLY inhibitor SB204990 (Targetmol, T16861), dimethyl Citrate (MCE, HY-N9542), and sodium acetate (Targetmol, T23377).
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
4

Cell Line Culturing Protocols

2025
HepG2, C3A, SK-HEP-1, PLC/PRF/5, SNU-387, SNU-423, SNU-449, and NK-92 cells were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA), and HuH7 cells from the Japanese Cancer Research Resources Bank (JCRB, Osaka, Japan). HepG2, C3A, SK-HEP-1, and PLC/PRF/5 cells were cultured in high-glucose Dulbecco’s minimum essential medium (Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS; Biological Industries, Israel), 1% HEPES buffer (Gibco), and 1% penicillin–streptomycin (PS; Gibco). SNU-387, SNU-423, and SNU-449 cells were cultured in RPMI-1640 medium (Nacalai Tesque, Kyoto, Japan) supplemented with 10% FBS, 1% HEPES buffer, and 1% PS. HuH7 cells were cultured in low-glucose Dulbecco’s minimum essential medium (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% FBS and 1% PS. NK-92 cells were cultured in α-minimum essential medium (Nacalai Tesque) composed of 20% FBS, 1% PS, 0.05 mM 2-mercaptoethanol (Nacalai Tesque), and 10 ng/mL interleukin (IL)-2 (Miltenyi Biotec, Bergisch Gladbach, Germany).
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
5

FIRRE Knockdown in HepG2 and Huh7 Cells

2025
The human HCC cell lines HepG2 and Huh7 was originally from ATCC and stocked in our laboratory. Cell line authentication was performed before use via short tandem repeats sequencing. Cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum, under a humidified atmosphere of 5% CO2 at 37 °C. Small interfering RNA (siRNA) against FIRRE was purchased from GenePharma (Shanghai, China), and sequences were as follows: si-FIRRE-1, 5’-CCAUGUACACCAUCAUCAATT-3’; si-FIRRE-2, 5’- GCCUAGGACCUUUGUG-GUATT-3’.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!

🧪 Need help with an experiment or choosing lab equipment?
I search the PubCompare platform for you—tapping into 40+ million protocols to bring you relevant answers from scientific literature and vendor data.
1. Find protocols
2. Find best products for an experiment
3. Validate product use from papers
4. Check Product Compatibility
5. Ask a technical question
Want to copy this response? Upgrade to Premium to unlock copy/paste and export options.